about
Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivityDiverse CD81 Proteins Support Hepatitis C Virus InfectionEffect of Cell Polarization on Hepatitis C Virus EntryCD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus EntryProtein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and InfectivityIdentification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesHepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cellsMutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityPolarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma CellsHepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus InternalizationCharacterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120Claudin association with CD81 defines hepatitis C virus entry.Hepatitis C virus induces CD81 and claudin-1 endocytosis.The role of the viral glycoprotein in HIV-1 persistence.Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.Inferring viral quasispecies spectra from 454 pyrosequencing reads.Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades.Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.Hepatitis C virus infection of neuroepithelioma cell lines.Neutralizing antibody response during acute and chronic hepatitis C virus infectionPermissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection.Hepatitis C virus infection of cholangiocarcinoma cell lines.In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors.Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent mannerAnalysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.Hepatitis C virus entry and neutralization.Hepatitis C virus infects the endothelial cells of the blood-brain barrier.Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in chinaStructural characterization of CD81-Claudin-1 hepatitis C virus receptor complexes.Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication.Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.Disease progression in heterosexual patients infected with closely related subtype B strains of HIV type 1 with differing coreceptor usage properties.Early infection events highlight the limited transmissibility of hepatitis C virus in vitro.A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration.
P50
Q24672232-363B7FE3-C782-48C1-A63A-3F8E542C5F0DQ27477625-AE26FDD2-385D-4930-A414-ED6428023903Q27485293-C7C13743-AB9D-458A-AF04-FE9A1FC05E2EQ27485899-43514F3D-3D1B-48F4-A9B1-85B1A6C39651Q27486784-7ADD994E-562C-4D80-B695-1224CDD915EEQ27487399-1AE29D90-2FFC-4D2A-8A5C-11422B8C7074Q27487754-0C2E2547-CA5F-441B-80AC-A2D5BB260757Q27488430-F87CCD53-02E5-4E67-9262-8DF7E4423CFEQ27488433-193900E6-4E02-45AB-8CAA-C702D89440E3Q27490466-A6AD8627-2DFD-46D7-9E00-71B5FC7702C0Q28646835-1C28A532-8B07-40B6-8116-994D752C0C47Q29465808-BDC6BFD8-C559-4753-848D-2C5D596FC9D6Q30512696-4C80FE46-00F5-41E3-B740-73147CBF28F6Q33538298-8896E274-BABD-45DE-B602-BA69BC66F4D7Q33602744-3930D85F-B07F-4F6D-90C5-EB68F7976FC5Q33739249-A61BDCE9-F8A4-462F-9F0E-9717BE905F47Q33841969-ECA9555D-5BAE-4CEC-A50F-5D5AE11F6245Q34046595-2D34EF98-14DF-4123-B7BB-CC9BD7B3EFBDQ34342200-49D87D76-60CA-4EB0-8EE5-58E372414008Q34459277-28EC9E5F-D438-411F-8CCB-3E000BD711D8Q34719734-0295477E-FB31-4C65-A886-7A83FE8B6B58Q35818245-E460BCE5-224E-4945-947D-CBCAA613F339Q35971609-D9602A16-78F9-4338-885B-1984EE04B275Q36255092-D6DB6B29-4B3D-4495-82DC-E2890BF31E68Q36255097-400F31A0-35FC-4C1D-94BB-2302DB31D475Q36546942-941FF0D5-6620-40F1-A8B0-6EAC9BE5F531Q36635229-A473A64E-F0F7-4043-9793-36F741055FD0Q36651761-D3617DAE-98AE-43AE-9863-82F301D620F5Q36694938-CAB6777E-976B-45AD-9F80-DAE0127801EDQ36795889-69FCC17C-3D96-454C-9CAE-139B8F790573Q36990362-D1A3F393-D359-4601-91E9-FAF9761ACC42Q37215799-40BBD41F-08C7-45CD-AFA0-22937EB9A321Q37241162-7D97B227-E8BB-411A-AEBA-AF63C95182ADQ37683012-53A77583-004C-4399-859D-4474F0BE5D71Q37856395-950338CF-F51A-44E1-BBC8-BE9D9BBCEFF2Q38843538-2089DE7F-344D-4CD7-A5F6-AC254E2793FEQ38996776-39F069E3-F680-4BAF-8ABD-BCB2883D518CQ39060000-6F9994FB-20B5-48A2-AECB-C0BF533D34B4Q39203981-7490E132-D00F-4E96-B89B-409B975BFFD1Q39426654-AA9372FD-A4FE-4E02-A335-7A82CD3F0DF3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Balfe
@ast
Peter Balfe
@en
Peter Balfe
@es
Peter Balfe
@nl
Peter Balfe
@sl
type
label
Peter Balfe
@ast
Peter Balfe
@en
Peter Balfe
@es
Peter Balfe
@nl
Peter Balfe
@sl
prefLabel
Peter Balfe
@ast
Peter Balfe
@en
Peter Balfe
@es
Peter Balfe
@nl
Peter Balfe
@sl
P106
P21
P31
P496
0000-0002-6246-0876